DeepCure was founded to accelerate breakthrough science, developed by world-leading AI engineers, data scientists and biologists.
Our founding team includes some of the industry’s preeminent drug-discovery scientists and technologists.
Our vision is to use AI-driven discovery to create better molecules and faster cures for every disease-relevant protein target.
Our founding team includes some of the industry’s preeminent drug-discovery scientists and technologists.
Our vision is to use AI-driven discovery to create better molecules and faster cures for every disease-relevant protein target.
Location: United States, Massachusetts, Boston
Employees: 11-50
Phone: +27 63 037 2939
Total raised: $104M
Founded date: 2018
Investors 4
| Date | Name | Website |
| - | E14 Fund M... | e14fund.co... |
| - | E14 Fund | e14.vc |
| 01.06.2021 | Creative D... | creativede... |
| - | TLV Partne... | tlv.partne... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 11.04.2024 | Series A | $24M | - |
| 01.12.2022 | Series A | $40M | - |
| 08.11.2021 | Series A | $40M | - |
Mentions in press and media 15
| Date | Title | Description |
| 03.03.2025 | DeepCure, Google and CWX Demonstrate the Potential For Chemistry LLMs To Increase Productivity In Medicinal Chemistry | BOSTON, MA, UNITED STATES, March 3, 2025 /EINPresswire.com/ -- DeepCure, a therapeutics company using AI to discover novel drugs for immune and inflammatory diseases, announced today the successful completion of a pilot program with Google ... |
| 11.04.2024 | DeepCure Closes $24M Series A-1 Funding | DeepCure, a Boston, MA-based developing novel, small molecule therapeutics powered by AI and automation of chemistry, raised $24M in Series A-1 funding. The round was led by IAG Capital Partners (IAG) with participation from current investo... |
| 12.11.2021 | StartUPDATES: New developments from healthcare startups | Carrum Health announced the appointment of former ConsumerMedical executive Randy K. Hawkins, M.D., FACHE as the company’s Chief Medical Officer (CMO). With nearly three decades of clinical experience as an anesthesiologist and senior healt... |
| 09.11.2021 | DeepCure scores $40M for AI-enabled drug discovery | Photo: poba/Getty Images |
| 09.11.2021 | DeepCure Closes $40M Series A Funding | DeepCure, a Boston, MA-based company developing novel, small molecule therapeutics using an AI drug discovery engine, closed a $40m Series A financing round. The round was led by Morningside Ventures, with participation from existing invest... |
| 08.11.2021 | DeepCure Gets $40M to Grow Its AI Drug Development Platform | Photo: Shutterstock Boston-based drug developer DeepCure announced Monday it raised $40 million in fresh funding. The Series A round was led by Morningside Venture, and makes up a lion’s share of the $47 million in funding the three-year-ol... |
| 08.11.2021 | Who would take venture dollars from Facebook right now? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. If you’re a startup founder, there’s a laundry list of reasons why you don’t want social media co... |
| 08.11.2021 | Who would take venture dollars from Facebook right now? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. If you’re a startup founder, there’s a laundry list of reasons why you don’t want social media co... |
| 08.11.2021 | DeepCure Closes $40M Series A Funding Led by Morningside Ventures | – Series A financing will catalyze growth and advance novel small molecule therapeutics pipeline across various disease indications – The funding will also be used to build an automated robotic wet lab to complete DeepCure’s vision of end-t... |
| 08.11.2021 | DeepCure Closes $40M Series A | BOSTON, MA, DeepCure, a startup developing small molecule therapeutics, announced the closing of a $40M Series A financing round led by Morningside Ventures. >> Click here for more funding data on DeepCure >> To export DeepC... |
Show more